Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gardner

Showing results (641-650 of 710) with videos related to

Pageof 71
Sort By:
Experimental Hematology|January 21, 2000
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansG Molineux, O Kinstler, B Briddell, et al.
Journal of Arrhythmia|October 17, 2024
"Real-world" performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx studyAndre Briosa E Gala, Michael T B Pope, Milena Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumorsW P Mason, A Grovas, S Halpern, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 29, 2016
Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3TColin G Stirrat, Shirjel R Alam, Thomas J MacGillivray, et al.
Circulation. Heart Failure|June 13, 2015
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function TrialAthar A Badar, Ana Cristina Perez-Moreno, Nathaniel M Hawkins, et al.
ESC Heart Failure|December 26, 2024
Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registryIgnacio García-Bolao, Roy S Gardner, Daniel Gras, et al.
Science (New York, N.Y.)|May 21, 2013
A reconciled estimate of glacier contributions to sea level rise: 2003 to 2009Alex S Gardner, Geir Moholdt, J Graham Cogley, et al.
European Heart Journal|October 1, 2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Athar A Badar, Ana Cristina Perez-Moreno, Pardeep S Jhund, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Glucokinase-activating ureasArlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Pageof 71

Showing results (641-650 of 710) with videos related to

Sort By:
Pageof 71
Experimental Hematology|January 21, 2000
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humansG Molineux, O Kinstler, B Briddell, et al.
Journal of Arrhythmia|October 17, 2024
"Real-world" performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx studyAndre Briosa E Gala, Michael T B Pope, Milena Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumorsW P Mason, A Grovas, S Halpern, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|July 29, 2016
Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3TColin G Stirrat, Shirjel R Alam, Thomas J MacGillivray, et al.
Circulation. Heart Failure|June 13, 2015
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina: Analysis of the Irbesartan in Patients With Heart Failure and Preserved Systolic Function TrialAthar A Badar, Ana Cristina Perez-Moreno, Nathaniel M Hawkins, et al.
ESC Heart Failure|December 26, 2024
Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registryIgnacio García-Bolao, Roy S Gardner, Daniel Gras, et al.
Science (New York, N.Y.)|May 21, 2013
A reconciled estimate of glacier contributions to sea level rise: 2003 to 2009Alex S Gardner, Geir Moholdt, J Graham Cogley, et al.
European Heart Journal|October 1, 2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Athar A Badar, Ana Cristina Perez-Moreno, Pardeep S Jhund, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Glucokinase-activating ureasArlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2023
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studiesJoanna Osmanska, Katriona Brooksbank, Kieran F Docherty, et al.
Pageof 71